Chang Min Lee Selected Research

kasugamycin

2/2022	Host Chitinase 3-like-1 is a Universal Therapeutic Target for SARS-CoV-2 Viral Variants in COVID 19.
1/2022	Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang Min Lee Research Topics

Disease

37	Stomach Neoplasms (Stomach Cancer) 03/2024 - 12/2010
13	Neoplasms (Cancer) 03/2024 - 12/2010
5	Gastroesophageal Reflux (GERD) 05/2023 - 07/2016
5	Inflammation (Inflammations) 02/2022 - 06/2008
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2017
3	COVID-19 02/2022 - 01/2022
3	Obesity 01/2022 - 02/2012
2	Weight Loss (Weight Reduction) 12/2023 - 12/2021
2	Type 2 Diabetes Mellitus (MODY) 12/2022 - 12/2017
2	Infections 02/2022 - 01/2022
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2019
2	Osteosarcoma (Osteogenic Sarcoma) 03/2019 - 01/2018
2	Flatulence 06/2018 - 01/2015
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2013
1	Cachexia 03/2024
1	Anorexia 03/2024
1	Respiratory Insufficiency (Respiratory Failure) 02/2024
1	Dyspnea (Shortness of Breath) 02/2024
1	Respiratory Sounds (Crackle) 02/2024
1	Hemorrhage 12/2023
1	Hypokalemia 01/2023
1	Situs Inversus 01/2023
1	Pressure Ulcer (Bedsore) 01/2023
1	Delirium 01/2023
1	Peptic Ulcer (Peptic Ulcers) 09/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 02/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Iron Deficiencies 01/2022
1	Anemia 01/2022
1	Morbid Obesity 12/2021
1	Diabetes Mellitus 12/2021
1	Colonic Neoplasms (Colon Cancer) 05/2021
1	Hypertension (High Blood Pressure) 04/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Insulin Resistance 01/2021
1	Thrombosis (Thrombus) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Ascites 01/2020
1	Bile Reflux 11/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2019

Drug/Important Bio-Agent (IBA)

4	Proton Pump InhibitorsIBA 12/2021 - 04/2016
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 01/2011
3	Capecitabine (Xeloda)FDA Link 03/2022 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2021
3	ChitinasesIBA 02/2022 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2019
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2022
2	tegafur-gimeracil-oteracilIBA 03/2022 - 06/2020
2	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 01/2022
2	kasugamycinIBA 02/2022 - 01/2022
2	CytokinesIBA 02/2022 - 06/2008
2	Anticarcinogenic AgentsIBA 01/2022 - 03/2019
2	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2017
2	C-Reactive ProteinIBA 01/2019 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2016
2	indole-3-carbinolIBA 01/2018 - 01/2018
1	Megestrol Acetate (Borea)FDA LinkGeneric 03/2024
1	Oxygen (Dioxygen)IBA 02/2024
1	BismuthIBA 09/2022
1	Moxifloxacin (Avelox)FDA Link 09/2022
1	Rifabutin (Ansamycin)FDA Link 09/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 02/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Rocuronium (Zemuron)FDA LinkGeneric 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	MicronutrientsIBA 01/2022
1	remdesivirIBA 01/2022
1	Telmisartan (Micardis)FDA Link 04/2021
1	LipidsIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	AntidiarrhealsIBA 01/2020
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 01/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	AcidsIBA 11/2019
1	Messenger RNA (mRNA)IBA 09/2019
1	Janus Kinase 2IBA 09/2019
1	tomentosinIBA 03/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2019

Therapy/Procedure

34	Gastrectomy 12/2023 - 01/2013
10	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2013
6	Therapeutics 09/2022 - 06/2009
5	Drug Therapy (Chemotherapy) 03/2024 - 01/2013
4	Length of Stay 01/2023 - 09/2013
4	Adjuvant Chemotherapy 08/2021 - 01/2014
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2023 - 01/2022
3	Bariatric Surgery 12/2023 - 12/2017
2	Fundoplication 05/2023 - 06/2018
2	Minimally Invasive Surgical Procedures 01/2023 - 09/2014
2	Splenectomy 06/2017 - 09/2013
1	Tracheostomy 02/2024
1	Operative Time 12/2023
1	Gastroenterostomy 01/2020
1	Pancreaticoduodenectomy 12/2019
1	Transplantation 01/2019
1	Surgical Anastomosis 01/2019